(Q29614305)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

Karina Elizabeth de Visser

30 April 2017

author

series ordinal

1

object named as

Karin E. de Visser

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

3

Lisa M. Coussens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

author name string

Eichten A

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

January 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

volume

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

issue

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

page(s)

24-37

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

NK cells in innate immunity

30 April 2017

cites work

1 reference

Close encounters of different kinds: dendritic cells and NK cells take centre stage

31 March 2020

1 reference

Interplay of natural killer cells and their receptors with the adaptive immune response

31 March 2020

1 reference

Inflammatory exposure and historical changes in human life-spans

31 March 2020

1 reference

Inflammation and cancer: back to Virchow?

31 March 2020

1 reference

The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma

31 March 2020

1 reference

Prognostic value of intratumoral natural killer cells in gastric carcinoma

31 March 2020

1 reference

Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma.

31 March 2020

1 reference

Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma

31 March 2020

1 reference

Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast

31 March 2020

1 reference

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

31 March 2020

1 reference

Infectious agents and cancer: criteria for a causal relation

31 March 2020

1 reference

Antibiotic use in relation to the risk of breast cancer

31 March 2020

1 reference

Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer

31 March 2020

1 reference

Sargramostim for active Crohn's disease

31 March 2020

1 reference

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

31 March 2020

1 reference

Immunosuppressive networks in the tumour environment and their therapeutic relevance

31 March 2020

1 reference

Where have all the T cells gone? Mechanisms of immune evasion by tumors

31 March 2020

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

31 March 2020

1 reference

Derangement of immune responses by myeloid suppressor cells

31 March 2020

1 reference

Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice

31 March 2020

1 reference

Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment.

31 March 2020

1 reference

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

31 March 2020

1 reference

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

31 March 2020

1 reference

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

31 March 2020

1 reference

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

31 March 2020

1 reference

Tumour-educated macrophages promote tumour progression and metastasis

31 March 2020

1 reference

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

31 March 2020

1 reference

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

31 March 2020

1 reference

Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma

31 March 2020

1 reference

New functions for the matrix metalloproteinases in cancer progression

31 March 2020

1 reference

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

31 March 2020

1 reference

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

31 March 2020

1 reference

MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis

31 March 2020

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

31 March 2020

1 reference

Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics

31 March 2020

1 reference

MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

31 March 2020

1 reference

Bisphosphonates in breast cancer.

31 March 2020

1 reference

COX-2 inhibitors--lessons in drug safety

31 March 2020

1 reference

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

31 March 2020

1 reference

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

31 March 2020

1 reference

Cyclooxygenases in cancer: progress and perspective

31 March 2020

1 reference

The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia

31 March 2020

1 reference

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

31 March 2020

1 reference

A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

31 March 2020

1 reference

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

31 March 2020

1 reference

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

31 March 2020

1 reference

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

31 March 2020

1 reference

Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB.

31 March 2020

1 reference

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

31 March 2020

1 reference

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

31 March 2020

1 reference

Clinical update: proteasome inhibitors in solid tumors

31 March 2020

1 reference

Aids-related malignancies

31 March 2020

1 reference

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

31 March 2020

1 reference

De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival

31 March 2020

1 reference

De novo malignancies after liver transplantation: a major cause of late death

31 March 2020

1 reference

Cancer immunotherapy: moving beyond current vaccines

31 March 2020

1 reference

CD8+ T cell tolerance and cancer immunotherapy

31 March 2020

1 reference

Breaking tolerance in cancer immunotherapy: time to ACT.

31 March 2020

1 reference

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

31 March 2020

1 reference

CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer

31 March 2020

1 reference

Regulation of cutaneous malignancy by gammadelta T cells

31 March 2020

1 reference

NKT cells and tumor immunity—a double-edged sword

31 March 2020

1 reference

Natural killer lymphocytes: biology, development, and function

31 March 2020

1 reference

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

31 March 2020

1 reference

Immune suppression and skin cancer development: regulation by NKT cells.

31 March 2020

1 reference

The interface between innate and adaptive immunity

31 March 2020

1 reference

Evolving concepts of rheumatoid arthritis

31 March 2020

1 reference

B cell depletion in autoimmune disease

31 March 2020

1 reference

Dendritic-cell trafficking to lymph nodes through lymphatic vessels

31 March 2020

1 reference

Tumor-associated immunoglobulins. Enhancement of syngeneic tumors by IgG2-containing tumor eluates.

31 March 2020

1 reference

The immune system during the precancer period: naturally-occurring tumor reactive monoclonal antibodies and urethane carcinogenesis.

31 March 2020

1 reference

Natural resistance mechanisms may play a role in protection against chemical carcinogenesis

31 March 2020

1 reference

Low antibody responsiveness is found to be associated with resistance to chemical skin tumorigenesis in several lines of Biozzi mice

31 March 2020

1 reference

Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies

31 March 2020

1 reference

Relative paradigms between autoantibodies in lupus and autoantibodies in cancer

31 March 2020

1 reference

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

31 March 2020

1 reference

Targeting B cells for the treatment of rheumatoid arthritis

31 March 2020

1 reference

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

31 March 2020

1 reference

Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer

31 March 2020

1 reference

Helicobacter pylori and gastric diseases: a dangerous association

31 March 2020

1 reference

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

31 March 2020

1 reference

Phagocytosis: elegant complexity

31 March 2020

1 reference

Cancer incidence in New York State acquired immunodeficiency syndrome patients.

31 March 2020

1 reference

Cancer risk in elderly persons with HIV/AIDS.

31 March 2020

1 reference

Association of Cancer With AIDS-Related Immunosuppression in Adults

31 March 2020

1 reference

Increased cancer risk after liver transplantation: a population-based study

31 March 2020

1 reference

Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future

31 March 2020

1 reference

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation

31 March 2020

1 reference

Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1018519640

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16397525

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017